首页> 外文OA文献 >10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

【2h】

10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

机译：有关欧洲儿科监管的10年报告及其对儿童癌症新药的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Andrew DJ Pearson; Delphine Heenen; Pamela R Kearns; Anne Goeres; Lynley V Marshall; Patricia Blanc; Gilles Vassal;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers [J] . Pearson Andrew D. J., Heenen Delphine, Kearns Pamela R., The lancet oncology . 2018,第3期

机译：有关欧洲儿科监管的10年报告及其对儿童癌症新药的影响
2. Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project [J] . Moreno Lucas, Caron Hubert, Geoerger Birgit, Expert opinion on drug discovery . 2017,第7a12期

机译：加速神经母细胞瘤的药物发育 - 新药开发战略：癌症儿童的创新疗法，儿童癌症研究和青少年癌症研究和国际小儿肿瘤学会欧洲神经母细胞瘤项目
3. Impact of the Food and Drug Administration (FDA)-European Medicines Agency (EMA) Common Commentary (CC) on Paediatric Cancer Drug Development [J] . Reaman G., Herold R., Norga K., Pediatric blood & cancer . 2016,第Suppla3期

机译：食品药品监督管理局（FDA）-欧洲药品管理局（EMA）共同评论（CC）对小儿癌症药物开发的影响
4. Architecture for an Advanced Biomedical Collaboration Domain for the European Paediatric Cancer Research Community (ABCD-4-E) [C] . Michael NITZLNADER, Markus FALGENHAUER, Christian GOSSY, Scientific eHealth Conference. . 2015

机译：欧洲儿科癌症研究界的高级生物医学协作领域的架构（ABCD-4-E）
5. Study on impacts of promotion of generic drug utilization on spontaneous adverse event reports and drug safety assessment at the post-market stage [D] . TAKAMI, Akina 2019

机译：上市后阶段推广仿制药利用对自发不良事件报告和药物安全评估的影响
6. The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children [O] . Annemarie Rosan Kreeftmeijer-Vegter, Anthonius de Boer, Roselinda H van der Vlugt-Meijer, 2014

机译：欧洲儿科法规对儿童孤儿药销售许可的影响
7. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium [O] . Alba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, 2020

机译：Covid-19在欧洲儿科早期癌症临床试验的影响：来自癌症（ITCC）联盟儿童的创新疗法的报告

10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

著录项

引文网络

相似文献

相关主题

期刊订阅